Ippon's Midatech to float

The amount the company plans to raise or how many shares it will sell has not yet been decided. Ippon currently holds a 16.5% stake in Midatech.

The company is expected to begin trading on the 12 December 2014. Panmure Gordon has been appointed as nominated adviser for the flotation.

Ippon backed Midatech in November last year, leading a £10m funding round for the company. Ippon supplied £7.6m of the total, with the balance provided by Midatech's existing investors.

Founded in 2000 and headquartered in Abingdon, Midatech is a developer of biocompatible gold nanoparticles, with a focus on healthcare applications including therapeutics, diagnostics and medical imaging. Its CEO is Jim Philips.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• United Kingdom
• IPO
• AIM
• LSE